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Background 
Phase I trials are the first stage in drug development. Major objectives include determining 
toxicities of new agents and maximum tolerated dose (MTD) for later clinical stages. The 3+3 
design is most common, although support is growing for newer “model-based” designs. One 
criticism of these is their complexity. To investigate gamification in teaching these designs to 
Cancer Science students, a computer game using Microsoft Kinect motion sensing was used 
to supplement existing lectures. 
Methods 
The game objective is to find MTD of “drug X”. Groups of 3-5 receive a draft trial protocol, 
pre-clinical toxicology report, and instructions for allometric scaling to human dose. Players 
first decide dose ranges to investigate. Using the game, patient cohorts are recruited, 
administered drug X, and toxicities checked. Players decide if dose limiting toxicity (DLT) is 
observed and whether to dose-escalate/de-escalate, expand the cohort, or stop. Each group 
plays a different trial design. Feedback was taken using a questionnaire investigating 
technology interaction, group working, learning outcomes and engagement. 
Results 
The game was tested with 3 student cohorts using different control methods (student-led, 
tutor-led, or mixed). 7/10, 7/8, and 12/21 students gave consent for analysis of their 
responses. Across cohorts, learner engagement items scored particularly highly. Nearly all 
also reported improved understanding of the concepts of DLT and MTD. Many also reported 
improved understanding of different phase I designs. Mann-Whitney analysis of responses 
under the different control conditions revealed few significant differences. Our favoured 
approach is mixed-mode control. 
Conclusions 
In the clinical trials education literature, studies of active learning approaches appear to be 
sparse. We have not yet formally evaluated student-reported learning improvements in a 
test/re-test setting. However, positive feedback across items of our questionnaire suggests 
that students value the activity. We envisage potential future extensions to the game 
addressing aspects of phase I design beyond recruitment and dosing. 
 
